AU4014800A - Treatment of gallstones - Google Patents

Treatment of gallstones

Info

Publication number
AU4014800A
AU4014800A AU40148/00A AU4014800A AU4014800A AU 4014800 A AU4014800 A AU 4014800A AU 40148/00 A AU40148/00 A AU 40148/00A AU 4014800 A AU4014800 A AU 4014800A AU 4014800 A AU4014800 A AU 4014800A
Authority
AU
Australia
Prior art keywords
gallstones
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40148/00A
Inventor
Carl M. Mendel
Timothy B. Seaton
Steve P. Weinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Pharmaceutical Co filed Critical Knoll Pharmaceutical Co
Publication of AU4014800A publication Critical patent/AU4014800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU40148/00A 1999-03-19 2000-03-17 Treatment of gallstones Abandoned AU4014800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12560999P 1999-03-19 1999-03-19
US60125609 1999-03-19
PCT/US2000/007199 WO2000056316A1 (en) 1999-03-19 2000-03-17 Treatment of gallstones

Publications (1)

Publication Number Publication Date
AU4014800A true AU4014800A (en) 2000-10-09

Family

ID=22420570

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40148/00A Abandoned AU4014800A (en) 1999-03-19 2000-03-17 Treatment of gallstones

Country Status (6)

Country Link
EP (1) EP1165060A4 (en)
JP (1) JP2002539252A (en)
AU (1) AU4014800A (en)
CA (1) CA2368416A1 (en)
MX (1) MXPA01009462A (en)
WO (1) WO2000056316A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
DE19518988A1 (en) * 1995-05-29 1996-12-05 Basf Ag Use of aryl substituted cyclobutylalkylamines to treat obesity

Also Published As

Publication number Publication date
EP1165060A4 (en) 2002-06-12
CA2368416A1 (en) 2000-09-28
WO2000056316A1 (en) 2000-09-28
EP1165060A1 (en) 2002-01-02
WO2000056316A8 (en) 2001-04-12
JP2002539252A (en) 2002-11-19
MXPA01009462A (en) 2004-03-19

Similar Documents

Publication Publication Date Title
AU7906100A (en) Use of retigabin for treating neuropathic pain
AU3791601A (en) Treatment of coal
AU5215300A (en) Dental treatment area
AU3896900A (en) Treatment of pain
AU5547000A (en) Novel treatment
AU1878201A (en) Composition for the treatment of damaged tissue
NZ513686A (en) Treatment of trauma
AU4556800A (en) Novel treatment
AU3760900A (en) Treatment of menstrual function
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2566201A (en) Compounds and methods for the treatment of pain
AU1618901A (en) Treatment of rosacea
AU1405001A (en) Treatment of diseases
AU4598400A (en) Method of treatment
AU2683500A (en) Compositions for the treatment of pain
AU2001253560A1 (en) Methods of treatment
AU4014800A (en) Treatment of gallstones
AU2382601A (en) Novel method of treatment
AU7455300A (en) The band combined medical treatment of ion
AU2420201A (en) Compounds and methods for the treatment of pain
AU7697500A (en) Acth treatment of steroid- and statin-treated patients
NZ514013A (en) Treatment of hiatial hernia
AUPQ361499A0 (en) Treatment of asthma
AUPQ385599A0 (en) Treatment of hypercholesterolaemia

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase